3
360 Haoyao
360 Haoyao is an online pharmacy marketplace
About 360 Haoyao
360 Haoyao, operating under the umbrella of 360 Health, marks a significant venture into China's burgeoning e-health market. The platform was launched in October 2015 by Guangzhou Youyi Information Technology Co., Ltd. and is spearheaded by Chen Hua, the former CEO of 1-Click-Pharmacy (1yaowang). Chen Hua's transition from a major online pharmacy to lead 360 Health underscores a strategic move to leverage his deep industry expertise in a new entrepreneurial context. The company secured a substantial Series A funding round of 100 million yuan (approximately $15.2 million) in May 2016, with Lilly Asia Ventures and SBCVC (SoftBank China Capital) as the lead investors. This investment, completed less than six months after the company's inception, highlights strong investor confidence in its business model and leadership.
360 Haoyao functions primarily as an open, third-party platform for pharmaceutical e-commerce, connecting consumers with a multitude of online drugstores. Rather than selling products directly, it serves as a comprehensive guide and search portal for consumers, aggregating offerings from partners like Jianke, Kangaiduo, and Laobaixing Online Pharmacy. The platform's revenue model is likely based on commissions, service fees, or a combination thereof from its partnered vendors. The product catalog is extensive, featuring everyday medicines, medical devices, health supplements, personal care items, and mother-and-baby products.
Beyond its consumer-facing marketplace, 360 Health has developed a robust technology-as-a-service arm for the pharmaceutical industry. It offers a technology cloud platform with two main products: "Tianji" and "Weizhan". Tianji is a specialized warehouse and supply chain management system designed for pharmaceutical e-commerce, encompassing ERP, WMS, and OMS modules. It provides these services to established pharmaceutical companies like Tongrentang, helping them digitize and streamline their operations. "Weizhan" is a cloud-based member service platform that equips pharmaceutical manufacturers with tools for fan management and distribution, aiming to enhance customer loyalty. This dual-platform strategy addresses two critical pain points for the industry: technology infrastructure and customer traffic, positioning 360 Health as a comprehensive service provider in the digital health sector.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 19.7/100
- Industry
- Health, Security
- Sub-industry
- BioTechnology, Public safety
- Sector
- Real Estate, Consumer Electronics, Biotechnology, Smart Home, Biotech and Pharma, Hard Tech
- Business model
- Marketplace & ecommerce
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2016 | $15M | $61M | SB China Capital · Lilly Asia Ventures | — |
Growth signals
Latest recorded traffic for 360 Haoyao is 30 monthly website visits, down 99.2% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
AntegenesGenetic tests for personalized cancer risk prevention |
Tartu, Estonia | Operational | 11 | $3.4M | $7M |
PharmaSentinel.comAI-powered regulatory and scientific medicines intelligence platform |
London, United Kingdom | Operational | |||
Gusto GlobalA biotherapeutics company that focuses on restoring key functionalities of a healthy microbiome |
Charlotte, United States | Operational | |||
Respire DiagnosticsNon-invasive breathalyzer for disease biomarker identification |
London, United Kingdom | Operational | |||
GelmetixInjectable polymer gel for non-surgical chronic pain treatment |
London, United Kingdom | Operational | |||
Alma Bio TherapeuticsDeveloping a new treatment that helps people with autoimmune disease |
Lyon, France | Closed | |||
PhagoMed BiopharmaDevelops endolysins and phage as therapeutics |
Vienna, Austria | Acquired | |||
RenovosNanoclay gel platform for regenerative medicine therapeutics |
Chilworth, United Kingdom | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
360 Haoyao in the Huangpu ecosystem
The 360 Haoyao office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
SB China Capital
Lilly Asia Ventures
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about 360 Haoyao on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See 360 Haoyao’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









